博济医药卿芷软膏临床试验获批

Core Viewpoint - The announcement from Beijing Boji Pharmaceutical indicates that its subsidiary, Guangzhou Boji New Drug Clinical Research Center, has received approval from the National Medical Products Administration for the clinical trial of "Qingzhi Ointment," marking a significant step in the development of a new traditional Chinese medicine [1] Group 1 - The "Qingzhi Ointment" is formulated based on traditional Chinese medicine principles and consists of multiple herbal ingredients [1] - It is classified as a Class 1 innovative traditional Chinese medicine that has not been marketed domestically or internationally [1] - The ointment is intended for the treatment of knee osteoarthritis with symptoms of wind-cold-dampness, focusing on dispelling wind, eliminating dampness, relieving cold, promoting circulation, and alleviating pain [1]